Orgenesis Inc. (NASDAQ:ORGS – Get Free Report) was down 3.3% during trading on Wednesday . The company traded as low as $0.50 and last traded at $0.50. Approximately 34,800 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 218,907 shares. The stock had previously closed at $0.52.
Orgenesis Stock Performance
The stock has a market capitalization of $17.42 million, a price-to-earnings ratio of -0.56 and a beta of 1.07. The company has a debt-to-equity ratio of 1.48, a quick ratio of 0.25 and a current ratio of 0.25. The business has a fifty day simple moving average of $0.65 and a 200 day simple moving average of $0.57.
About Orgenesis
Orgenesis Inc, a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network.
Further Reading
- Five stocks we like better than Orgenesis
- What is a SEC Filing?
- 3 Stocks Leading the U.S. Agriculture Comeback
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- How to Choose Top Rated Stocks
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
